Bloomberg Intelligence

The US and Iran agreed to a two-week ceasefire that’s expected to halt the American-Israeli military campaign in exchange for Tehran reopening the Strait of Hormuz.

President Donald Trump announced the agreement Tuesday on social media hours after Pakistan, a mediator in talks, implored the US leader to back off his deadline to unleash massive devastation on Iran if it did not meet his demands. The deal buys time for the two sides to reach a longer agreement to end the six-week-old war, which has killed thousands of people and sparked a global energy crisis.
Trump said he had agreed “to suspend the bombing and attack of Iran for a period of two weeks” as long as Iran agrees to “the COMPLETE, IMMEDIATE, and SAFE OPENING of the Strait of Hormuz.”

For instant reaction and analysis, Bloomberg Radio host Doug Krizner speaks with:

Bloomberg State Department and Foreign Policy Reporter Eric Martin
Bloomberg This Weekend co-host Christina Ruffini
Bloomberg White House and Washington correspondent Jeff Mason
Terry Haines, founder of Pangea Policy
Daniel Byman, Director of the Warfare, Irregular Threats, and Terrorism Program at the Center
See omnystudio.com/listener for privacy information.

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney, Emily Graffeo, and Alexis Christoforous

-Matthew Bloxham, Bloomberg Intelligence Senior and Tech Analyst, discusses Bill Ackman's investment firm Pershing Square Capital Management pitching a deal to combine Universal Music Group with an acquisition vehicle publicly traded in the US.

-Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the latest on Broadcom. Anthropic confirmed plans to work with Broadcom and Google to power its operations.

-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Gilead Sciences agreed to buy private German biotech Tubulis GmbH in a deal worth up to $5 billion to boost its portfolio in cancer drug development. Novo Nordisk will price its new high-dose Wegovy shot at $399 a month for cash-pay patients, undercutting the cost of most doses of rival Eli Lilly & Co.’s Zepbound.
-Lloyd Arnold, BNEF Data Center Reporter, discusses data centers. The digital infrastructure boom is continuing apace despite jitters in equity markets and fears of a “bubble”. The capital expenditure of the 14 largest publicly owned data center operators globally is seen close to $750 billion this year against a little less than $450 billion last year.
See omnystudio.com/listener for privacy information.

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

-- Tim Craighead, Bloomberg Intelligence Global Chief Content Officer, discusses 10 companies to watch right now in 2Q. Bloomberg Intelligence analysts have identified the most interesting names from their group of high-confidence Focus Ideas. Spanning sectors and regions, each scenario outlines a catalyst in the next few months.

- Youkyung Lee, Bloomberg Asia Stocks Reporter, discusses Micron Technology. Micron Technology is facing challenges in the stock market, with its shares down nearly 20% since hitting a high three weeks ago due to concerns about the memory sector and uncertainty in the broader market.

-Anurag Rana, Bloomberg Intelligence Technology Analyst, discusses Apple and how the company could boost its AI standing with the revamp of its Siri virtual assistant in June. Anurag also discusses Oracle naming Hilary Maxson as CFO, effective April 6th.

-Katherine Chiglinsky, Bloomberg US Finance Team Leader, discusses JPMorgan Chase CEO Jamie Dimon’s letter to shareholders Monday, saying the US needs to “get stronger” in order to maintain its military and economic might.
See omnystudio.com/listener for privacy information.

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

- David Welch, Bloomberg Detroit Bureau Chief, discusses Tesla sales. Tesla Inc. posted one of its worst sales quarters in years, missing Wall Street’s expectations, as the carmaker struggles to turn around its core business and navigate an increasingly challenged electric-vehicle market.
Separately, Stellantis is discussing options for building electric vehicles in Canada with its Chinese partner, Zhejiang Leapmotor Technology Co. The talks are in an early stage and focused on an idled Stellantis assembly plant in Brampton, Ontario, with the possibility of building cars in partnership with Leapmotor.

- Brody Ford, Bloomberg Technology Reporter, discusses the Bloomberg Big Take story “Microsoft CFO’s AI Spending Runs Up Against Tech Bubble Fears.”
Description:
Microsoft Chief Financial Officer Amy Hood must decide how much to spend on artificial intelligence without starving other parts of the company or alarming Wall Street. In this executive profile, Bloomberg exclusively reports that Hood made the call to pause data center construction last year, a controversial decision some say left the company without enough computing power for its AI services.

- Robert Schiffman, Senior Tech Credit Analyst for Bloomberg Intelligence, discusses how Intel’s turnaround is advancing as spending is cut.
According to Bloomberg Intelligence: Intel's new CEO is stabilizing the company's credit profile, refocusing core-product franchises and cutting costs. It's still a work in progress, but reductions in operating expenses and capital spending are paying off, enabling Intel to buy back a $14.2 billion stake in its Ireland fabrication joint venture without jeopardizing its investment grade profile.
See omnystudio.com/listener for privacy information.

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

- Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, discusses SpaceX filing confidentially for an initial public offering, bringing the company closer to delivering the biggest-ever listing. The company submitted its draft IPO registration to the US Securities and Exchange Commission and could seek a valuation in the IPO of more than $1.75 trillion.

-Lily Meier, Bloomberg Retail Reporter, discusses Nike earnings. Nike Inc. shares fell after the company gave a gloomy outlook for the year ahead, with revenue expected to decline 2% to 4% in the current quarter. The company is facing headwinds around the globe, including elevated inventories in Europe and the Middle East and weakness in Greater China and other areas.

-Lindsay Dutch, Bloomberg Intelligence Consumer Hardlines Senior Analyst, recaps earnings from RH. RH shares plunged after the home furnishing company forecast revenue for the first quarter that missed the average analyst estimate.

See omnystudio.com/listener for privacy information.